‹ All stocks
Drugs Made In America Acquisition Corp. Rights
DMAAR · NASDAQ · Financial Services
$0.13
— $0.13 (0.00%)
Day range
$0.13 – $0.13
Year range
$0.04 – $0.21
Open
$0.13
Previous close
—
Market cap
$287.76M
Volume (24h)
$8.0K
Volume (52w)
$1.02K
Performance
7D
▲ 2.08%
1M
▲ 8.51%
3M
▲ 24.15%
6M
▲ 112.50%
1Y
▼ -14.37%
YTD
▼ -14.37%
3Y
▼ -14.37%
5Y
▼ -14.37%
All-time
▼ -14.37%
Key statistics
P/E ratio
—
EPS (TTM)
—
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
2.3B
About Drugs Made In America Acquisition Corp. Rights
Drugs Made In America Acquisition Corp. (DMAAR) is a special purpose acquisition company (SPAC), established with the primary objective of identifying and acquiring one or more active businesses or their assets. The company plans to achieve these acquisitions through various transactional structures, including mergers, exchanges of equity shares, direct asset purchases, stock acquisitions, or broader corporate reorganizations.
Visit websiteCountry: United States of America
More in Financial Services
BRK-B Berkshire Hathaway |
$500.50 | 0.51% |
JPM JPMorgan Chase & Co. |
$333.18 | 0.71% |
V Visa |
$359.85 | 0.14% |
MA Mastercard Incorporated |
$550.00 | -0.27% |
BAC Bank of America |
$53.73 | -1.29% |